Cargando…
An omics perspective on drug target discovery platforms
The drug discovery process starts with identification of a disease-modifying target. This critical step traditionally begins with manual investigation of scientific literature and biomedical databases to gather evidence linking molecular target to disease, and to evaluate the efficacy, safety and co...
Autores principales: | Paananen, Jussi, Fortino, Vittorio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711264/ https://www.ncbi.nlm.nih.gov/pubmed/31774113 http://dx.doi.org/10.1093/bib/bbz122 |
Ejemplares similares
-
ThETA: transcriptome-driven efficacy estimates for gene-based TArget discovery
por: Failli, Mario, et al.
Publicado: (2020) -
Prioritizing target-disease associations with novel safety and efficacy scoring methods
por: Failli, Mario, et al.
Publicado: (2019) -
Publisher Correction: Prioritizing target-disease associations with novel safety and efficacy scoring methods
por: Failli, Mario, et al.
Publicado: (2020) -
“Omics”-Informed Drug and Biomarker Discovery: Opportunities, Challenges and Future Perspectives
por: Matthews, Holly, et al.
Publicado: (2016) -
Knowledge Generation with Rule Induction in Cancer Omics
por: Scala, Giovanni, et al.
Publicado: (2019)